Dendreon Pharmaceuticals, LLC

Dendreon Pharmaceuticals, LLC

Dendreon is a commercial-stage biopharmaceutical company and end-to-end provider of manufacturing services for the cell therapy market. Dendreon was founded on the belief that immunotherapy made form a patient’s own cells will transform disease treatment. Our product PROVENGE® (sipuleucel-T) was the first FDA-approved immunotherapy to harness the innate benefits of personalized cellular treatment made from a patient’s own immune cells. Now Dendreon is helping to advance other cell therapies from clinic to market by leveraging its development and commercialization experience.

Yes